Accessibility Menu
 
Resverlogix logo

Resverlogix

(OTC) RVXCF

Current Price$0.08
Market Cap$24.17M
Since IPO (2012)-96%
5 Year-89%
1 Year+151%
1 Month-11%

Resverlogix Financials at a Glance

Market Cap

$24.17M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.76M

EPS (TTM)

$-0.03

P/E Ratio

-3.06

Dividend

$0.00

Beta (Volatility)

0.53 (Low)

Price

$0.08

Volume

100

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.08

52-Week Range

$0.02 - $0.21

RVXCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Resverlogix

Industry

Biotechnology

Employees

18

CEO

Donald J. McCaffrey

Headquarters

Calgary, AB T3E 6L1, CA

RVXCF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

14%

Return on Assets

-1%

Earnings Yield

-32.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.17M

Shares Outstanding

315.92M

Volume

100

Short Interest

0.00%

Avg. Volume

7.97K

Financials (TTM)

Gross Profit

$437.53K

Operating Income

$5.20M

EBITDA

$4.77M

Operating Cash Flow

$3.73M

Capital Expenditure

$9.16K

Free Cash Flow

$3.73M

Cash & ST Invst.

$107.80K

Total Debt

$72.77M

Resverlogix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$120.28K

-37.5%

Gross Margin

0.00%

N/A

Market Cap

$24.17M

N/A

Market Cap/Employee

$1.27M

N/A

Employees

19

N/A

Net Income

$209.17K

-144.8%

EBITDA

$348.00K

+127.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$72.66M

-3.6%

Accounts Receivable

$910.34K

+277.7%

Inventory

$434.21K

-56.4%

Long Term Debt

$52.01M

-16.0%

Short Term Debt

$20.76M

+149.0%

Return on Assets

-1.02%

N/A

Return on Invested Capital

14.19%

N/A

Free Cash Flow

$1.04M

+3.0%

Operating Cash Flow

$1.03M

-3.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BBIXFBonus BioGroup Ltd.
$0.02+0.00%
ZHCLFZenith Capital Corp.
$0.14+0.00%
MEDIFMediPharm Labs Corp.
$0.05-3.81%
CLYYFCelyad Oncology S.A.
$0.35+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$188.67+0.03%
AMZNAmazon
$238.43+0.02%
TSLATesla
$348.76+0.01%
SKYQSky Quarry
$12.59+0.73%

Questions About RVXCF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.